TA Associates Announces Investment in Healix BOSTON & SUGAR LAND, Texas, December 18, 2017-- TA Associates, a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Healix, a provider of outsourced alternate-site infusion therapy management services. Financial terms of the transaction were not disclosed. Founded in 1989 by Alan Chaveleh and Mort Baharloo, Healix is a leading provider of infusion therapy management services and compounded intravenous pharmaceuticals for physician practices and hospitals.